This work is licensed under a Creative Commons Attribution 4.0 International License.
PBP-2
General Information
DRACP ID DRACP01167
Peptide Name PBP-2
Sequence CVRARTR
Sequence Length 7
UniProt ID Not available
PubChem CID Not available
Origin Not available
Type Synthetic peptide
Classification
Active ACP
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| CT26 | Mouse colon adenocarcinoma | Carcinoma | As show in fig4 | Mouse model anti-tumor assay | 24 days | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C33H64N16O9S
Absent amino acids DEFGHIKLMNPQSWY
Common amino acids R
Mass 96823
Pl 12.2
Basic residues 3
Acidic residues 0
Hydrophobic residues 2
Net charge 3
Boman Index -4020
Hydrophobicity -81.43
Aliphatic Index 55.71
Half Life
Mammalian: 1.2 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID EP3725799A1
Patent Title Peptide Bound to Pl-L1 and Use Thereof
Other Iinformation Patent Application; Family: 5s / 6ex; Family Jurisdictions: EP, KR, US; Legal Status: Pending; Application No: 18888477; Filed: Dec 17, 2018; Published: Oct 21, 2020; Earliest Priority: Dec 15, 2017
Other Published ID EP3725799A4 KR102150419B1 KR20190072466A US2021163534A1
This work is licensed under a Creative Commons Attribution 4.0 International License.